| Date Filed | Type | Description |
| 09/29/2023 |
4
| Patel Sanjiv (President and CEO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Granted 1,662 shares
@ $10.68, valued at
$17.8k
|
|
| 09/29/2023 |
4
| Rahmer Peter (See remarks) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Granted 1,662 shares
@ $10.68, valued at
$17.8k
Sold 244 shares
@ $8.38, valued at
$2k
|
|
| 09/29/2023 |
4
| Catinazzo Thomas (CFO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 294 shares
@ $8.38, valued at
$2.5k
|
|
| 09/29/2023 |
4
| Adams Brian (Chief Legal Officer) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 294 shares
@ $8.38, valued at
$2.5k
|
|
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2023 |
4
| Rahmer Peter (See remarks) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 244 shares
@ $12.12, valued at
$3k
|
|
| 06/28/2023 |
4
| Catinazzo Thomas (CFO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 294 shares
@ $12.12, valued at
$3.6k
|
|
| 06/28/2023 |
4
| Bergstrom Donald A (President, R&D) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 647 shares
@ $12.12, valued at
$7.8k
|
|
| 06/28/2023 |
4
| Adams Brian (Chief Legal Officer) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 294 shares
@ $12.12, valued at
$3.6k
|
|
| 06/01/2023 |
4
| HILL LINDA A (Director) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Granted 66,055 options to buy
@ $11.14, valued at
$735.9k
|
|
| 06/01/2023 |
4
| INGRAM DOUGLAS S (Director) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Granted 66,055 options to buy
@ $11.14, valued at
$735.9k
|
|
| 06/01/2023 |
4
| Kathiresan Sekar (Director) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Granted 66,055 options to buy
@ $11.14, valued at
$735.9k
|
|
| 06/01/2023 |
4
| Murcko Mark (Director) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Granted 66,055 options to buy
@ $11.14, valued at
$735.9k
|
|
| 06/01/2023 |
4
| Rubin Jami (Director) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Granted 66,055 options to buy
@ $11.14, valued at
$735.9k
|
|
| 06/01/2023 |
4
| Shawver Laura (Director) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Granted 66,055 options to buy
@ $11.14, valued at
$735.9k
|
|
| 06/01/2023 |
4
| Borisy Alexis (Director) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Granted 66,055 options to buy
@ $11.14, valued at
$735.9k
|
|
| 06/01/2023 |
4
| Rahmer Peter (See remarks) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Granted 161,818 shares
@ $0 |
|
| 06/01/2023 |
4/A
| Rahmer Peter (See remarks) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 1,657 shares
@ $11.16, valued at
$18.5k
|
|
| 06/01/2023 |
4/A
| Catinazzo Thomas (CFO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 2,012 shares
@ $11.16, valued at
$22.5k
|
|
| 06/01/2023 |
4/A
| Bergstrom Donald A (President, R&D) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 2,850 shares
@ $11.16, valued at
$31.8k
|
|
| 06/01/2023 |
4/A
| Adams Brian (Chief Legal Officer) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 1,936 shares
@ $11.16, valued at
$21.6k
|
|
| 05/26/2023 |
4
| Shawver Laura (Director) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Gifted 12,099 shares
@ $0 |
|
| 05/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/01/2023 |
4
| Catinazzo Thomas (CFO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 863 shares
@ $11.16, valued at
$9.6k
|
|
| 05/01/2023 |
4
| Bergstrom Donald A (President, R&D) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 1,383 shares
@ $11.16, valued at
$15.4k
|
|
| 05/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2023 |
4
| Patel Sanjiv (President and CEO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 14,000 shares
@ $21.45, valued at
$300.3k
Sold 14,000 shares
@ $20.98, valued at
$293.7k
Sold 14,000 shares
@ $20.55, valued at
$287.7k
Exercised 14,000 options to buy
@ $5.04, valued at
$70.6k
Exercised 14,000 options to buy
@ $5.04, valued at
$70.6k
Exercised 14,000 options to buy
@ $5.04, valued at
$70.6k
|
|
|